When sports icon David Beckham signed on as a strategic investor, few anticipated that Prenetics would soon take a pioneering leap into cryptocurrency. Yet on June 18, Nasdaq-listed Prenetics announced a bold $20 million foray into Bitcoin—making it the first healthcare firm to officially hold BTC on its balance sheet. This decision sparked both stock market excitement and broader discussions about how healthcare may tap blockchain’s potential.
A Historic Bitcoin Move in Healthcare
Prenetics established an ownership stake of approximately 187.4 BTC, purchased at an average cost of $106,712 per coin, safely hailing with Kraken custody. The scale of this move is notable: out of 60+ non-crypto businesses implementing treasury strategies of this kind, Prenetics is the only company from the healthcare sector. Prenetics’ stock gained sharply by 23% in the wake of the announcement.
Why Now? Financial Muscle & Strategic Timing
Prenetics’ head start has stemmed from a now sturdier financial positon. Its true liquidity is approximately $117 million with $66 million of cash, short-term assets and the bitcoin itself—also including the sell off proceeds of ACT Genomics. The company has zero debt and has also shared an updated revised guidance with revenues of $80–100 million in 2025 with the expectation of profitability by Q4 together. Against a backdrop of growing institutional interest in crypto—and comparables like MicroStrategy achieving over $60 billion in BTC holdings—Prenetics’ strategy appears calculated and timely.
Assembling a Crypto-Savvy Leadership Team
To anchor its initiative, Prenetics has brought heavyweight talent onto its board and advisory units. Former OKEx COO Andy Cheung joins the board, offering decade-long experience in crypto operations and institutional strategies. Meanwhile, advisors Tracy Hoyos Lopez—who influenced President Trump’s Bitcoin stance—and Raphael Strauch, founder of Token2049, bring expertise in regulatory policy and global crypto networks. This leadership ensemble signals both credibility and long-term commitment.
Beyond the Purchase: A Broader Web3 Blueprint
Prenetics isn’t just holding BTC – they’re looking for an integrated digital assets ecosystem. The company will;
- Allocate the predominance of its balance sheet to Bitcoin;
- Use dynamic treasury tools – including derivatives, yield farming, and structured products – for returns;
- Enable Bitcoin payment acceptance across its customer brands including IM8 Health and CircleDNA by year-end.
As CEO Danny Yeung simply stated in a recent podcast: “we’re at the beginning of an epoch dawn, where genomics, personalized medicine, and digital assets will intersect…”.
Broader Implications: Sports, Healthcare & Crypto Convergence
Though Beckham’s role doesn’t appear operational in the crypto strategy, his association enhances visibility—especially within the sporting world, which has flirted with NFTs, fan tokens, and crypto sponsorships. Prenetics’ move may inspire healthcare firms and professional sports ecosystems alike to explore blockchain-supported innovation.
Conclusion
Prenetics’ $20 million investment in Bitcoin highlights a trend of companies diversifying their treasury strategies across fields—from technology and finance to healthcare. Prenetics has an excellent balance sheet, experienced leadership and a complex vision for digital assets, making them leaders at the intersection of biotech and crypto. A transformative test project could become a case study—where genomes, wellness, and crypto reframes our ways of thinking about health, wellness and economic sustainability.
